Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-009266
Filing Date
2023-01-17
Accepted
2023-01-17 14:07:59
Documents
7
Period of Report
2023-01-17

Document Format Files

Seq Description Document Type Size
1 6-K d761411d6k.htm 6-K 10172
2 EX-99.1 d761411dex991.htm EX-99.1 33104
3 EX-99.2 d761411dex992.htm EX-99.2 38543
4 EX-99.3 d761411dex993.htm EX-99.3 13803
5 GRAPHIC g761411g0113211324628.jpg GRAPHIC 2601
6 GRAPHIC g761411g0113211400175.jpg GRAPHIC 2601
7 GRAPHIC g761411g0113211400402.jpg GRAPHIC 1154
  Complete submission text file 0001193125-23-009266.txt   106015
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 23531184
SIC: 2834 Pharmaceutical Preparations